मुख्य सामग्री पर जाएं

Molnupiravir for COVID-19 disease

Lagevrio

Molnupiravir is given to adults aged over 18 years when they have tested positive for COVID-19 and have at least one risk factor for developing severe illness.

Treatment should be started as soon as possible after diagnosis and within the first five days of symptoms.

The most common side-effects are feeling sick (nausea) and diarrhoea.

एक नजर में

  • Molnupiravir is an antiviral medicine for adults with mild to moderate COVID-19.

  • It helps stop the COVID-19 virus from replicating in your body.

  • It is for adults with COVID-19 who have risk factors for severe illness.

  • Take four capsules every 12 hours for five days.

  • Common side-effects can include diarrhoea, feeling sick, and dizziness.

के लिए वीडियो चयन संक्रमण उपचार दवा

नीचे पढ़ना जारी रखें

About molnupiravir

दवा का प्रकार

Antiviral agent

के लिए उपयोग किया जाता है

Treatment of mild to moderate COVID-19 disease in adults

जिसे कहा जाता है

Lagevrio®

के रूप में उपलब्ध

Capsules

Molnupiravir is an antiviral agent that works by combining with viral RNA to stop the virus particles from replicating. If a virus can't replicate it won't be able to infect other cells in the body and the infection won't spread as quickly. Molnupiravir can reduce the severity of viral infections such as COVID-19.

Molnupiravir is used for adults who have tested positive for COVID-19 and have at least one risk factor for severe disease. Taking molnupiravir as soon as possible once COVID-19 symptoms have started can lower your risk of being severely ill or requiring hospitalisation.

People at high risk of severe COVID-19 disease include those with medical conditions such as long-term heart, lung, liver, kidney or nerve problems, people with diabetes and people with weakened immune systems.

Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start taking molnupiravir it is important that your doctor knows:

  • If you are pregnant, trying for a baby, or breastfeeding.

  • यदि आपको कभी किसी दवा से एलर्जी की प्रतिक्रिया हुई है।.

  • यदि आप कोई अन्य दवाएं ले रहे हैं। इसमें वे सभी दवाएं शामिल हैं जो आप बिना पर्ची के खरीद सकते हैं, साथ ही हर्बल और पूरक दवाएं भी शामिल हैं।.

नीचे पढ़ना जारी रखें

  • Before you start this treatment, read the manufacturer's printed information leaflet from inside your pack. The manufacturer's leaflet will give you more information about molnupiravir and a full list of side-effects which you may experience from taking it.

  • The usual dose of molnupiravir is four capsules (800 mg) taken every twelve hours for five days. Make sure you complete the course even if you are feeling better.

  • Swallow the capsules whole with a drink of water. Do not open, crush or chew the capsules.

  • It is not important whether you take molnupiravir capsules before or after food.

  • If you forget to take a dose, take it as soon as you remember unless it is nearly time for your next dose. In which case, leave out the forgotten dose and take your next dose when it is due. Do not take two doses together to make up for a missed dose.

  • Treatment with molnupiravir should be started within the first five days of COVID-19 symptoms or as soon as possible after a positive COVID-19 test result.

  • Make sure you complete the full course of treatment even if you start to feel better or do not feel unwell.

  • Help your body fight the infection by drinking plenty of water, eating sensibly and getting plenty of rest.

  • The best way to protect yourself from COVID-19 is through vaccination. Ensure your vaccinations are up to date in line with national guidance.

नीचे पढ़ना जारी रखें

Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains some of the most common ones associated with molnupiravir. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.

Common molnupiravir side-effects (affecting fewer than 1 in 10 people)

अगर मुझे यह अनुभव होता है तो मैं क्या कर सकता हूँ?

दस्त

Drink plenty of water to replace lost fluids

Feeling sick (nausea)

Stick to simple foods. Try taking your doses with something to eat if you are not already doing so

चक्कर आना

Do not drive and do not use tools or machines if affected

Important: In rare cases this medicine may cause a serious allergic reaction. Seek urgent medical attention if you develop a red, itchy skin rash and any difficulties with your breathing, including swelling of the face, lips or tongue. Taking an antihistamine may help slow the reaction whilst you are waiting for treatment.

If you experience any other symptoms which you think may be due to this medicine, speak with your doctor or pharmacist.

  • सभी दवाओं को बच्चों की पहुँच और दृष्टि से दूर रखें।.

  • ठंडी, सूखी जगह पर रखें, सीधे गर्मी और रोशनी से दूर।.

सभी दवाओं के बारे में महत्वपूर्ण जानकारी

निर्धारित खुराक से अधिक कभी न लें। यदि आपको संदेह है कि आपने या किसी और ने इस दवा की अधिक मात्रा ले ली है, तो अपने स्थानीय अस्पताल के दुर्घटना और आपातकालीन विभाग में जाएं। कंटेनर को अपने साथ ले जाएं, भले ही वह खाली हो।.

यह दवा आपके लिए है। इसे कभी भी अन्य लोगों को न दें, भले ही उनकी स्थिति आपकी जैसी ही क्यों न लगे।.

पुरानी या अनचाही दवाइयाँ न रखें। उन्हें अपने स्थानीय फार्मेसी में ले जाएँ, जो उन्हें आपके लिए नष्ट कर देगा।.

यदि इस दवा के बारे में आपके कोई प्रश्न हैं तो अपने फार्मासिस्ट से पूछें।.

दवा या टीके के दुष्प्रभावों की रिपोर्ट करें

यदि आपको दुष्प्रभाव महसूस होते हैं, तो आप उन्हें ऑनलाइन रिपोर्ट कर सकते हैं येलो कार्ड वेबसाइट.

लक्षण जाँचकर्ता

दवाओं को मिलाने के बारे में अनिश्चित?

दवाओं, सप्लीमेंट्स और खाद्य पदार्थों के बीच संभावित इंटरैक्शन की जांच करें, उन्हें एक साथ लेने से पहले।.

अक्सर पूछे जाने वाले प्रश्न

What is the purpose of molnupiravir if I already have COVID-19?

Molnupiravir is an antiviral medicine used for adults who have tested positive for COVID-19 and have risk factors for severe disease. It works by stopping the virus from replicating, which can reduce the severity of the illness and lower your risk of needing hospitalisation.

Who is considered at high risk for severe COVID-19 disease and would benefit from molnupiravir?

People at high risk for severe COVID-19 include those with long-term medical conditions affecting the heart, lungs, liver, kidneys, or nerves, as well as individuals with diabetes and those with weakened immune systems.

How quickly after getting COVID-19 symptoms or a positive test should I start taking molnupiravir?

Treatment with molnupiravir should be started as soon as possible, ideally within the first five days of COVID-19 symptoms appearing or after receiving a positive COVID-19 test result.

Are there any specific foods or drinks I should avoid while taking molnupiravir?

The article states that it doesn't matter whether you take molnupiravir capsules before or after food. If you experience feeling sick (nausea), it suggests sticking to simple foods or trying to take your doses with something to eat. There are no specific foods or drinks mentioned to avoid.

What happens if I miss a dose of molnupiravir?

If you forget to take a dose, take it as soon as you remember. However, if it's almost time for your next dose, you should skip the missed dose and take your next dose as scheduled. Do not take a double dose to make up for the one you missed.

Besides taking the medication, what else can I do to help my body recover from COVID-19?

To help your body fight the infection, it's recommended to drink plenty of water, eat sensibly, and get plenty of rest. Additionally, ensuring your COVID-19 vaccinations are up to date is the best way to protect yourself from the virus.

अधिक पठन और संदर्भ

नीचे पढ़ना जारी रखें

लेखक के बारे मेंपूरा जीवन परिचय देखें

लेखक की छवि

Michael Stewart, MRPharmS

दवा पत्रक समीक्षा प्रबंधक – ठेकेदार, फार्मासिस्ट

BPharm (Hons), MRPharmS

माइकल मिडलैंड्स और साउथ यॉर्कशायर में एक सामुदायिक फार्मासिस्ट हैं, जो दवाओं और चिकित्सा स्थितियों पर सलाह देने में 20 से अधिक वर्षों का अनुभव रखते हैं। उनके पास स्वास्थ्य देखभाल प्रशिक्षण में मजबूत पृष्ठभूमि है, उन्होंने फार्मेसी टीमों और आवासीय देखभाल सेटिंग्स के कर्मचारियों, जिनमें नर्सें शामिल हैं, के लिए प्रशिक्षण पाठ्यक्रम तैयार और प्रस्तुत किए हैं। उन्होंने समुदाय में कम तीव्रता वाली स्थितियों के प्रबंधन के लिए फार्मेसी सलाहकार बोर्डों में भी योगदान दिया है।.

समीक्षक के बारे में

लेखक की छवि

Sid Dajani

सुल्तान दाजानी ने 1994 में लंदन स्कूल ऑफ फार्मेसी से योग्यता प्राप्त की और 1842 में इसकी स्थापना के बाद से रॉयल फार्मास्यूटिकल सोसाइटी परिषद के सबसे युवा निर्वाचित सदस्य बने।.

लेख का इतिहास

इस पृष्ठ पर दी गई जानकारी योग्य चिकित्सकों द्वारा लिखी और सहकर्मी समीक्षा की गई है।.

  • Next review due: 15 Dec 2027
  • 15 Dec 2024 | नवीनतम संस्करण

    द्वारा अंतिम अपडेट

    Michael Stewart, MRPharmS

    द्वारा सहकर्मी समीक्षा की गई

    Sid Dajani
फ्लू पात्रता जाँचकर्ता

पूछें, साझा करें, जुड़ें।.

चर्चाओं को ब्राउज़ करें, प्रश्न पूछें, और सैकड़ों स्वास्थ्य विषयों पर अनुभव साझा करें।.

पेशेंट न्यूज़लेटर के लिए साइन अप करें

आपकी साप्ताहिक खुराक स्पष्ट, विश्वसनीय स्वास्थ्य सलाह की - जो आपको सूचित, आत्मविश्वासी और नियंत्रण में महसूस करने में मदद करने के लिए लिखी गई है।.

कृपया एक मान्य ईमेल पता दर्ज करें

सदस्यता लेने पर आप हमारी स्वीकार करते हैं गोपनीयता नीति. आप किसी भी समय सदस्यता समाप्त कर सकते हैं। हम कभी भी आपका डेटा नहीं बेचते।.